Header
For Healthcare Professionals

Evidences on renal safety / microalbuminuria

Prof Merlin Thomas, Dr Sarah Jarvis

Prof Merlin Thomas, Dr Sarah Jarvis

i) CARMELINA the only DPP4i CVOT to assess 'hard' kidney ourcomes
ii) Trajenta reduce progression of albuminuria
iii) CARMELINA reassures is safe for renal impairment patients
iv) Linagliptin not associated with increased risk of HHF

Related content

Not All DPP4i are the same-dosing & simplicity
Prof Merlin Thomas, Dr Sarah Jarvis

Not All DPP4i are the same-dosing & simplicity

  • 1.10.2022
What’s the first thing that comes to mind, when you hear the word “simplicity".png
J.M Co

What’s the first thing that comes to mind, when you hear the word “simplicity”?

  • 1.1.2023
How has the type 2 diabetes landscape changed, before and after the availability of DPP4-inhibitors (2).jpg
J.M Co, Prof Cooper

How has the type 2 diabetes landscape changed, before and after the availability of DPP4-inhibitors?

  • 1.1.2023